Report Categories
View AllRecent Articles
View All
Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline
IMDX Q1 2026 Earnings EPS beats estimates by 55 despite revenue absence
SHLS Q1 2026 Earnings EPS Beats Expectations as Operations Remain Steady
APC Q1 2026 Earnings EPS Beats Estimates Amid Revenue NonDisclosure Stock Slides
CPK Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower